NCT03964480
Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.
StatusRecruiting
PhaseNot specified
Primary completion (estimated)
At risk: Primary completion moved 1 year 5 months later.
See at-risk trials from Associazione Angela Serra per la ricerca sul cancro
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 3 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Jul 30, 2025 to Dec 30, 2026 Show 6 more changesShow less
- Enrollment increased: 1000 → 1500 participants
- Eligibility criteria expanded, about 27 words
- Study completion pushed from Jul 30, 2025 to Dec 30, 2027
- Study description revised
- Site details revised at 1 of 6 sites
- Publications: details revised at 44 of 46 entries
- Notable Primary completion date: Jan 30, 2023 to Jul 30, 2025
- Site contacts updated at 1 of 6 sites
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Progression-free survival (PFS)
Timeframe: 2 year
Secondary (4)
Overall Survival (OS)
Progression-Free Survival (PFS)
Event Free Survival (EFS)
Complete Response Rate (CR)
Sites
6 sites in 4 countries
Italy 3, Romania 1, Ukraine 1, United States 1